Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages 100247
Publisher
Elsevier BV
Online
2023-06-11
DOI
10.1016/j.modpat.2023.100247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Utilization of genetic testing in men with advanced prostate cancer
- (2023) Jonathan A. Aguiar et al. PROSTATE
- Germline Testing in Prostate Cancer: Implementation and Disparities of Care
- (2023) Landon C. Brown et al. JCO Oncology Practice
- Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification
- (2023) Rohit Mehra et al. MODERN PATHOLOGY
- Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
- (2022) Vipulkumar Dadhania et al. BMC CANCER
- A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies
- (2022) Nitin Singhal et al. Scientific Reports
- Cell Cycle Progression Score, But Not PTEN Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-Risk Prostate Cancer in Men Treated with and without Salvage Radiotherapy
- (2022) Bruce J. Trock et al. JOURNAL OF UROLOGY
- Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
- (2021) Rebeca Lozano et al. EUROPEAN JOURNAL OF CANCER
- Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Christopher Sweeney et al. LANCET
- Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
- (2021) Saman Farahmand et al. MODERN PATHOLOGY
- GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States
- (2021) Igor Vidal et al. PLoS One
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
- (2020) Wassim Abida et al. JOURNAL OF CLINICAL ONCOLOGY
- Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study
- (2020) Rikiya Yamashita et al. LANCET ONCOLOGY
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
- (2019) Jakob Nikolas Kather et al. NATURE MEDICINE
- Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
- (2018) Harsimar B. Kaur et al. MODERN PATHOLOGY
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
- (2018) Nicolas Coudray et al. NATURE MEDICINE
- Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
- (2018) Johann S. de Bono et al. CLINICAL CANCER RESEARCH
- Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study
- (2017) Jennifer M. Hoskovec et al. Journal of Genetic Counseling
- Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay
- (2017) Alba Torres et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
- (2017) Tamara L. Lotan et al. Oncotarget
- Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
- (2016) Ashley E. Ross et al. EUROPEAN UROLOGY
- Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
- (2016) Tamara L Lotan et al. MODERN PATHOLOGY
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis
- (2015) Gail P. Risbridger et al. EUROPEAN UROLOGY
- Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
- (2014) F. Khani et al. CLINICAL CANCER RESEARCH
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
- (2013) B Gumuskaya et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia
- (2012) Tamara L Lotan et al. MODERN PATHOLOGY
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
- (2011) Alcides Chaux et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer
- (2010) Tarek A. Bismar et al. BJU INTERNATIONAL
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Clinicopathologic Factors Identify Sporadic Mismatch Repair–Defective Colon Cancers
- (2008) Britta Halvarsson et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now